FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161050336> ?p ?o ?g. }

• W2161050336 abstract "For patients chronically infected with hepatitis C virus (HCV), mutations in the non-structural 5A (NS5A) gene are important predictive factors for the response to interferon (IFN) therapy. In the present study, factor analysis of the therapeutic response of patients following pegylated IFN and ribavirin combination therapy was assessed in a multicenter study. Chronic HCV-infected patients with genotype 1b and high viral load (n=96, mean age 56.5 years; 59 males, 68 females) treated with pegylated IFN-α-2b and ribavirin combination therapy were enrolled. This study was conducted at Kobe University Hospital and 25 affiliated hospitals in Hyogo prefecture. Sixty-five patients (68%) completed treatment with both pegylated IFN and ribavirin at >80% of the weight-based scheduled dosages. Patients who reduced or terminated therapy were frequently aged women (mean age 60.8 years; 11 males, 17 females). Overall, a sustained viral response (SVR) was achieved in 42 (44%) patients out of 96. Based on per-protocol-based (PPB) analysis, the SVR rate in patients with ≥6 amino acid (aa) mutations in the IFN resistance-determining region (IRRDR) (75%) or ≥1 aa mutation in the IFN sensitivity-determining region (ISDR) (61%) was significantly higher than that in patients with <5 aa mutations in IRRDR (30%) or no mutation in ISDR (29%). Multivariate analysis revealed that rapid viral response (RVR) (odds ratio, 18.1) and mutations of ≥6 in IRRDR (odds ratio, 15.5) were significantly associated with SVR. In conclusion, mutations in the NS5A region, particularly in patients with ≥6 aa mutations in IRRDR were strongly associated with a therapeutic response to pegylated IFN and ribavirin combination therapy." @default.
• W2161050336 created "2016-06-24" @default.
• W2161050336 creator A5001514470 @default.
• W2161050336 creator A5002542647 @default.
• W2161050336 creator A5015596711 @default.
• W2161050336 creator A5017765466 @default.
• W2161050336 creator A5020434543 @default.
• W2161050336 creator A5027118627 @default.
• W2161050336 creator A5027328092 @default.
• W2161050336 creator A5030124901 @default.
• W2161050336 creator A5032830870 @default.
• W2161050336 creator A5035559767 @default.
• W2161050336 creator A5043945477 @default.
• W2161050336 creator A5048664261 @default.
• W2161050336 creator A5049690579 @default.
• W2161050336 creator A5051606026 @default.
• W2161050336 creator A5060214425 @default.
• W2161050336 creator A5066738011 @default.
• W2161050336 creator A5069442914 @default.
• W2161050336 creator A5070100086 @default.
• W2161050336 creator A5077112374 @default.
• W2161050336 creator A5080356868 @default.
• W2161050336 creator A5083369232 @default.
• W2161050336 creator A5089317397 @default.
• W2161050336 creator A5090361524 @default.
• W2161050336 creator A5091465155 @default.
• W2161050336 date "2012-08-09" @default.
• W2161050336 modified "2023-09-22" @default.
• W2161050336 title "Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C" @default.
• W2161050336 cites W1723221221 @default.
• W2161050336 cites W1964494489 @default.
• W2161050336 cites W1968426124 @default.
• W2161050336 cites W1969456701 @default.
• W2161050336 cites W1988699908 @default.
• W2161050336 cites W1991019633 @default.
• W2161050336 cites W1998859748 @default.
• W2161050336 cites W2003104968 @default.
• W2161050336 cites W2013679732 @default.
• W2161050336 cites W2014165835 @default.
• W2161050336 cites W2026614040 @default.
• W2161050336 cites W2027252289 @default.
• W2161050336 cites W2027545702 @default.
• W2161050336 cites W2036364486 @default.
• W2161050336 cites W2041961923 @default.
• W2161050336 cites W2043976325 @default.
• W2161050336 cites W2050776853 @default.
• W2161050336 cites W2052669811 @default.
• W2161050336 cites W2057809644 @default.
• W2161050336 cites W2079317094 @default.
• W2161050336 cites W2102518994 @default.
• W2161050336 cites W2112835058 @default.
• W2161050336 cites W2112876622 @default.
• W2161050336 cites W2127685726 @default.
• W2161050336 cites W2136978386 @default.
• W2161050336 cites W2169391152 @default.
• W2161050336 cites W2335845212 @default.
• W2161050336 cites W2461724232 @default.
• W2161050336 doi "https://doi.org/10.3892/ijmm.2012.1093" @default.
• W2161050336 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22899224" @default.
• W2161050336 hasPublicationYear "2012" @default.
• W2161050336 type Work @default.
• W2161050336 sameAs 2161050336 @default.
• W2161050336 citedByCount "6" @default.
• W2161050336 countsByYear W21610503362013 @default.
• W2161050336 countsByYear W21610503362014 @default.
• W2161050336 countsByYear W21610503362015 @default.
• W2161050336 crossrefType "journal-article" @default.
• W2161050336 hasAuthorship W2161050336A5001514470 @default.
• W2161050336 hasAuthorship W2161050336A5002542647 @default.
• W2161050336 hasAuthorship W2161050336A5015596711 @default.
• W2161050336 hasAuthorship W2161050336A5017765466 @default.
• W2161050336 hasAuthorship W2161050336A5020434543 @default.
• W2161050336 hasAuthorship W2161050336A5027118627 @default.
• W2161050336 hasAuthorship W2161050336A5027328092 @default.
• W2161050336 hasAuthorship W2161050336A5030124901 @default.
• W2161050336 hasAuthorship W2161050336A5032830870 @default.
• W2161050336 hasAuthorship W2161050336A5035559767 @default.
• W2161050336 hasAuthorship W2161050336A5043945477 @default.
• W2161050336 hasAuthorship W2161050336A5048664261 @default.
• W2161050336 hasAuthorship W2161050336A5049690579 @default.
• W2161050336 hasAuthorship W2161050336A5051606026 @default.
• W2161050336 hasAuthorship W2161050336A5060214425 @default.
• W2161050336 hasAuthorship W2161050336A5066738011 @default.
• W2161050336 hasAuthorship W2161050336A5069442914 @default.
• W2161050336 hasAuthorship W2161050336A5070100086 @default.
• W2161050336 hasAuthorship W2161050336A5077112374 @default.
• W2161050336 hasAuthorship W2161050336A5080356868 @default.
• W2161050336 hasAuthorship W2161050336A5083369232 @default.
• W2161050336 hasAuthorship W2161050336A5089317397 @default.
• W2161050336 hasAuthorship W2161050336A5090361524 @default.
• W2161050336 hasAuthorship W2161050336A5091465155 @default.
• W2161050336 hasBestOaLocation W21610503361 @default.
• W2161050336 hasConcept C104317684 @default.
• W2161050336 hasConcept C126322002 @default.
• W2161050336 hasConcept C135763542 @default.
• W2161050336 hasConcept C142462285 @default.
• W2161050336 hasConcept C156957248 @default.
• W2161050336 hasConcept C159047783 @default.
• W2161050336 hasConcept C203014093 @default.
• W2161050336 hasConcept C2522874641 @default.

• next